This bill reenacts and amends the definitions section of chapter 71.05 RCW. The amendment expands the statutory definition of "gravely disabled" to expressly include a person who within the two weeks prior to initial detention required revival by opioid overdose reversal medication. It also clarifies numerous definitions used throughout the chapter, defines secure withdrawal management and stabilization facilities and their required functions, states that no medical clearance is required before a designated crisis responder investigates a person presenting in the community, allows the Health Care Authority to certify single temporary evaluation and treatment beds, permits physically separate portions of state hospitals to be designated as evaluation and treatment facilities and excludes correctional institutions from being such facilities. The bill requires secure withdrawal management and stabilization facilities to provide assessment and treatment by certified substance use disorder professionals or co‑occurring disorder specialists, clinical stabilization and detoxification services, discharge assistance (including facilitating transitions to appropriate inpatient services or less restrictive alternatives), security measures to protect patients and staff, and licensing or certification by the Department of Health. It also defines treatment records to include mental health information contained in medical bills and to exclude personal-use notes not available to others. Legally, the bill modifies existing law (it reenacts and amends RCW 71.05.020) and makes definitional and procedural changes and licensing/certification requirements; it does not create a new crime or change criminal penalties in the extracted text. The act links section timing so that section 1 expires when section 2 takes effect, and section 2 becomes effective when the contingency in section 26, chapter 433, Laws of 2023 takes effect; the specific contingency or dates are not provided in the extracted material. Several portions of definitions and the full list of services for secure withdrawal management and stabilization facilities are cut off in the provided excerpts, so some definitional text and service details remain incomplete in this summary.

If enacted, more people who recently needed naloxone or other opioid overdose reversal to be revived (within the prior two weeks) can be treated as "gravely disabled," making them more likely to be detained for evaluation or involuntary treatment. Designated crisis responders can investigate people who present in the community without waiting for a medical clearance, and secure withdrawal management and stabilization facilities will have to provide specified clinical services, security, licensed oversight, and active discharge planning by certified substance use disorder or co‑occurring disorder specialists. Health care entities most affected include counties (and their designated crisis responders), the Department of Health (licensing and certification), hospitals and treatment facilities, DSHS, and behavioral health providers; they can expect more urgent evaluations, greater demand for inpatient or stabilized care, and new licensing and staffing obligations. Those parties are likely to face increased operational and compliance costs: facilities may need to add security, hire or certify substance use disorder professionals and co‑occurring specialists, and pursue Department of Health licensure or certification; counties and crisis responder systems may face heavier workloads and coordination duties with tribes and providers. The authority’s ability to certify single temporary evaluation beds could ease short‑term capacity strain, but the bill’s timing and some implementation details are unclear—Section 2’s effective date depends on a contingency in a 2023 law and portions of the required services and definitions are not fully shown here—so the scope and timing of costs and enforcement remain uncertain.